Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy

American Journal of Pathology

Volumn 167, Issue 2, 2005, Pages 599-607

  Al Shabrawey, Mohamed ^a   Bartoli, Manuela ^a   El Remessy, Azza B ^a   Platt, Daniel H ^a   Matragoon, Sue ^a   Behzadian, M Ali ^a   Caldwell, Robert W ^a   Caldwell, Ruth B ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOCYNIN; DICHLOROFLUORESCEIN; ENZYME INHIBITOR; GLYCOPROTEIN GP 91; HYDROETHIDINE; LIPID PEROXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE INHIBITOR; SUPEROXIDE; UNCLASSIFIED DRUG; VASCULOTROPIN; ACETOPHENONE DERIVATIVE; CYBB PROTEIN, MOUSE; MEMBRANE PROTEIN; OXYGEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG TARGETING; ENZYME INHIBITION; GENE OVEREXPRESSION; HYPOXIA; IMMUNOLOCALIZATION; IN VITRO STUDY; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; ANIMAL; ANOXIA; C57BL MOUSE; CATTLE; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; ISCHEMIA; METABOLISM; PATHOLOGY; RETINA; RETINA DISEASE; UPREGULATION;

ACETOPHENONES; ANIMALS; ANOXIA; CATTLE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; ISCHEMIA; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NADPH OXIDASE; OXYGEN; RETINA; RETINAL DISEASES; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; SUPEROXIDES; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 25144513156     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63001-5     Document Type: Article

References (46)

1. Lee P, Wang CC, Adamis AP: Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 1998, 43:245-269
2. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris III FL, Klein R: Diabetic retinopathy. Diabetes Care 1998, 21:143-156
3. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA: Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995, 113:1538-1544
4. Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, Caldwell RW: Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev 2003, 19:442-455
5. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 1997, 18:4-25
6. Fu XW, Wang D, Nurse CA, Dinauer MC, Cutz E: NADPH oxidase is an O2 sensor in airway chemoreceptors: evidence from K+ current modulation in wild-type and oxidase-deficient mice. Proc Natl Acad Sci USA 2000, 97:4374-4379
7. Zhu H, Qiu H, Yoon HW, Huang S, Bunn HF: Identification of a cytochrome b-type NAD(P)H oxidoreductase ubiquitously expressed in human cells. Proc Natl Acad Sci USA 1999, 96:14742-14747
8. Adams ER, Dratz EA, Gizachew D, Deleo FR, Yu L, Volpp BD, Vlases M, Jesaitis AJ, Quinn MT: Interaction of human neutrophil flavocytochrome b with cytosolic proteins: transferred-NOESY NMR studies of a gp91phox C-terminal peptide bound to p47phox. Biochem J 1997, 325:249-257
9. Wenger RH, Marti HH, Schuerer-Maly CC, Kvietikova I, Bauer C, Gassmann M, Maly FE: Hypoxic induction of gene expression in chronic granulomatous disease-derived B-cell lines: oxygen sensing is independent of the cytochrome b558-containing nicotinamide adenine dinucleotide phosphate oxidase. Blood 1996, 87:756-761
10. Jones SA, O'Donnell VB, Wood JD, Broughton JP, Hughes EJ, Jones OT: Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol 1996, 271:H1626-H1634
11. Bayraktutan U, Draper N, Lang D, Shah AM: Expression of functional neutrophil-type NADPH oxidase in cultured rat coronary microvascular endothelial cells. Cardiovasc Res 1998, 38:256-262
12. Li JM, Shah AM: Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem 2002, 277:19952-19960
13. Kuroki M, Voest EE, Amano S, Beerepoot LV, Takashima S, Tolentino M, Kim RY, Rohan RM, Colby KA, Yeo KT, Adamis AP: Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 1996, 98:1667-1675
14. Ellis EA, Guberski DL, Somogyi-Mann M, Grant MB: Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 2000, 28:91-101
15. Ellis EA, Grant MB, Murray FT, Wachowski MB, Guberski DL, Kubilis PS, Lutty GA: Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 1998, 24:111-120
16. El-Remessy AB, Behzadian MA, Abou-Mohamed G, Franklin T, Caldwell RW, Caldwell RB: Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am J Pathol 2003, 162:1995-2004
17. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R: A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 2000, 87:26-32
18. Gorlach A, Diebold I, Schini-Kerth VB, Berchner-Pfannschmidt U, Roth U, Brandes RP, Kietzmann T, Busse R: Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22(phox)-containing NADPH oxidase. Circ Res 2001, 89:47-54
19. Brandes RP, Miller FJ, Beer S, Haendeler J, Hoffmann J, Ha T, Holland SM, Gorlach A, Busse R: The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. Free Radic Biol Med 2002, 32:1116-1122
20. Brandes RP: Role of NADPH oxidases in the control of vascular gene expression. Antioxid Redox Signal 2003, 5:803-811
21. Sen CK, Khanna S, Babior BM, Hunt TK, Ellison EC, Roy S: Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing. J Biol Chem 2002, 277:33284-33290
22. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA: Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994, 35:101-111
23. Brooks SE, Gu X, Samuel S, Marcus DM, Bartoli M, Huang PL, Caldwell RB: Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice. Invest Ophthalmol Vis Sci 2001, 42:222-228
24. Gu X, Samuel S, El-Shabrawey M, Caldwell RB, Bartoli M, Marcus DM, Brooks SE: Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci 2002, 43:496-502
25. Behzadian MA, Wang XL, Shabrawey M, Caldwell RB: Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-beta. Glia 1998, 24:216-225
26. Al-Shabrawey M, El-Remessy A, Gu X, Brooks SS, Harmed MS, Huang P, Caldwell RB: Normal vascular development in mice deficient in endothelial NO synthase: possible role of neuronal NO synthase. Mol Vis 2003, 9:549-558
27. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989, 161:851-858
28. Miller Jr FJ, Gutterman DD, Rios CD, Heistad DD, Davidson BL: Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 1998, 82:1298-1305
29. Hart BA, Simons JM: Metabolic activation of phenols by stimulated neutrophils: a concept for a selective type of anti-inflammatory drug. Biotechnol Ther 1992, 3:119-135
30. Stolk J, Hiltermann TJ, Dijkman JH, Verhoeven AJ: Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol 1994, 11:95-102
31. Rey FE, Cifuentes ME, Kiarash A, Quinn MT, Pagano PJ: Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res 2001, 89:408-414
32. Jacobson GM, Dourron HM, Liu J, Carretero OA, Reddy DJ, Andrzejewski T, Pagano PJ: Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery. Circ Res 2003, 92:637-643
33. Cai H, Griendling KK, Harrison DG: The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 2003, 24:471-478
34. Munzel T, Afanas'ev IB, Kleschyov AL, Harrison DG: Detection of superoxide in vascular tissue. Arterioscler Thromb Vasc Biol 2002, 22:1761-1768
35. Imada I, Sato EF, Miyamoto M, Ichimori Y, Minamiyama Y, Konaka R, Inoue M: Analysis of reactive oxygen species generated by neutrophils using a chemiluminescence probe L-012. Anal Biochem 1999, 271:53-58
36. Penn JS: Oxygen-induced retinopathy in the rat: possible contribution of peroxidation reactions. Doc Ophthalmol 1990, 74:179-186
37. Smith LE: Pathogenesis of retinopathy of prematurity. Semin Neonatol 2003, 8:469-473
38. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE: Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 1995, 92:905-909
39. Jones RD, Hancock JT, Morice AH: NADPH oxidase: a universal oxygen sensor? Free Radic Biol Med 2000, 29:416-424
40. Verdejo C, Marco P, Renau-Piqueras J, Pinazo-Duran MD: Lipid peroxidation in proliferative vitreoretinopathies. Eye 1999, 13:183-188
41. Du Y, Miller CM, Kern TS: Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med 2003, 35:1491-1499
42. Abid MR, Kachra Z, Spokes KC, Aird WC: NADPH oxidase activity is required for endothelial cell proliferation and migration. FEBS Lett 2000, 486:252-256
43. Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, Fujimoto M, Quinn MT, Pagano PJ, Johnson C, Alexander RW: Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 2002, 91:1160-1167
44. Liu SX, Chiang CH, Yao QS, Chiou GC: Increase of ocular blood flow by some phytogenic compounds. J Ocul Pharmacol Ther 1996, 12:95-101
45. Cotter MA, Cameron NE: Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats. Life Sci 2003, 73:1813-1824
46. Archer SL, Reeve HL, Michelakis E, Puttagunta L, Waite R, Nelson DP, Dinauer MC, Weir EK: O2 sensing is preserved in mice lacking the gp91 phox subunit of NADPH oxidase. Proc Natl Acad Sci USA 1999, 96:7944-7949